Ionis Pharmaceuticals Inc (NAS:IONS)
$ 35.91 -0.42 (-1.16%) Market Cap: 5.74 Bil Enterprise Value: 4.73 Bil PE Ratio: 0 PB Ratio: 8.65 GF Score: 40/100

Ionis Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2021 / 08:40PM GMT
Release Date Price: $59.15 (-4.75%)
Jessica Macomber Fye
JPMorgan Chase & Co, Research Division - Analyst

Great. Good afternoon, everyone. My name is Jess Fye. I'm one of the senior biotech analysts at JPMorgan. And we're continuing the 2021 healthcare conference today with Ionis. I'm joined by the company's CEO, Brett Monia.

And I wanted to let you know that instead of going across the hall for a breakout session after the presentation, this year, you can ask a question by clicking the blue Ask a Question button on the webcast. This will send them to me through a portal, and I can ask them to management after the presentation.

So with that out of the way, let me turn it over to Brett.

Brett P. Monia
Ionis Pharmaceuticals, Inc. - Founder, CEO & Director

Thank you, Jess, and good afternoon, everybody. Thanks for joining me today for this presentation. Very pleased to present to you on Ionis Pharmaceuticals, where we are today and what our future looks like from our perspective, a very bright and exciting future.

My understanding is that you listeners will be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot